Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas

被引：0
|
作者：
Locke, Margaret [1 ,4 ]
Kohn, Nina [2 ]
Seetharamu, Nagashree [3 ]
机构：
[1] Zucker Sch Med Hofstra Northwell, Dept Internal Med, Manhasset, NY USA
[2] Northwell Hlth, Off Acad Affairs, Manhasset, NY USA
[3] Northwell Hlth, Monter Canc Ctr, Manhasset, NY USA
[4] 300 Community Dr, Manhasset, NY 11030 USA
来源：
CLINICAL OTOLARYNGOLOGY | 2023年 / 48卷 / 06期
关键词：
chemotoxicity; head and neck cancer; metastatic disease; unresectable head and neck cancer; CHEMOTHERAPY; RECURRENT;
D O I：
10.1111/coa.14091
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：915 / 919
页数：5
相关论文
共 50 条
  • [11] Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Roy, C. Le
    Vernerey, D.
    Evin, C.
    Richard, S.
    Crespel, C.
    Samaille, T.
    Tourneau, C. Le
    Huguet, F.
    CLINICAL ONCOLOGY, 2022, 34 (12) : E473 - E481
  • [12] Weekly Paclitaxel plus Cetuximab in the primary treatment of metastatic/recurrent squamous cell cancer of head and neck
    Taira, Shinichiro
    Nakano, Kenji
    Tomomatsu, Junichi
    Marshall, Shouko
    Takahashi, Shunji
    ANNALS OF ONCOLOGY, 2016, 27
  • [13] Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Takeshita, Naohiro
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Wada, Akihisa
    Sato, Masanobu
    Tanaka, Hideki
    Tanaka, Nobukazu
    Onaga, Ryutaro
    Hoshi, Yuta
    Sakashita, Shingo
    Ishii, Genichiro
    Tahara, Makoto
    ORAL ONCOLOGY, 2023, 147
  • [14] Efficacy and tolerance of carboplatin-cetuximab in patients with metastatic or recurrent head and neck squamous cell carcinoma unfit for extreme regimen.
    Le Roy, Charlotte
    Vernerey, Dewi
    Evin, Cecile
    Crespel, Celine
    Samaille, Thomas
    Le Tourneau, Christophe
    Huguet, Florence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [15] Cetuximab in squamous cell head and neck carcinomas
    Gebbia, V.
    Giuliani, F.
    Valori, V. M.
    Agueli, R.
    Coiucci, G.
    Maiello, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 5 - 7
  • [16] Quality of life of elderly patients receiving weekly carboplatin and paclitaxel chemotherapy plus cetuximab first line for metastatic squamous cell carcinoma of the head and neck
    Lugini, A.
    Rossi, R.
    Pace, R.
    Rauco, A.
    Santarelli, M.
    Capparella, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S752 - S752
  • [17] Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Tanaka, Ryoko
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Togashi, Takafumi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1133 - 1141
  • [18] Weekly Paclitaxel, Carboplatin, and Cetuximab (PCC) as Treatment for Recurrent or Metastatic Head and Neck Squamous-cell Carcinoma (RM-HNSCC) that Progressed on Immune Checkpoint Inhibitors (ICI): A Retrospective Analysis
    Bonomi, M.
    Abu-Sbeih, H.
    Klamer, B.
    Issa, M.
    Rind, F.
    Dibs, K.
    Konieczkowski, D. J.
    Gogineni, E.
    Pan, J.
    Old, M.
    Tili, E.
    Chakravarti, A.
    Grecula, J. C.
    Baliga, S.
    Carrau, R.
    Rocco, J. W.
    Blakaj, D. M.
    Bhateja, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E41 - E42
  • [19] Weekly paclitaxel, carboplatin and cetuximab (PCC) combination followed by nivolumab in platinum-sensitive recurrent and/or metastatic squamous cell carcinoma of head and neck: A double institution retrospective analysis from India
    Agarwala, V.
    Chandrakanth, M. V.
    Mondal, P. K.
    Chanana, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1350 - S1350
  • [20] A comparison of cetuximab-containing regimens for recurrent/metastatic squamous cell head and neck carcinoma: the clinical significance of weekly paclitaxel and cetuximab
    Nakano, K.
    Marshall, S.
    Taira, S.
    Sato, Y.
    Tomomatsu, J.
    Sasaki, T.
    Shimbashi, W.
    Fukushima, H.
    Yonekawa, H.
    Mitani, H.
    Kawabata, K.
    Takahashi, S.
    ANNALS OF ONCOLOGY, 2016, 27
12345